US Patent Issued on Sept. 15 for "Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders" (Illinois Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,142, issued on Sept. 15.

"Use of a cinnamein composition for the treatment of glycine encephalopathy and urea cycle disorders" was invented by Kalipada Pahan (Skokie, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to pharmaceutical compositions and/or formulations useful for the treatment of diseases and disorders. More particularly, the disclosure relates to pharmaceutical compositions and/or formulations comprising the cinnamic acid analogue, cinnamein, for the treatment of glycine encephalopathy and urea cycle disorders."

The patent was filed on April 25, 2023, under Application No. 18/306,697.

*Fo...